What is the CONNECT1-EDO51 study?

The CONNECT1-EDO51 clinical trial is a research study for people who are living with Duchenne muscular dystrophy (Duchenne). The study will test whether an investigational drug, called PGN-EDO51, is safe and tolerable for boys and men with Duchenne. CONNECT1-EDO51 is an open-label study, meaning that everyone who agrees to take part in the study and meets the required criteria to participate will receive PGN-EDO51.

Who can join the CONNECT1-EDO51 study?

Study participants may be able to join the study if they meet the following requirements:

Other study requirements will apply.

What will happen during the study?

Participation in a clinical study is voluntary. You can ask any questions you have and may leave the study at any time, for any reason.

If you have additional questions about participating in this clinical research study, please send an email to to learn more.

Privacy PolicyTerms and Conditions